A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell (Q33361776)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell |
scientific article |
Statements
1 reference
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell (English)
1 reference
Massimo Loda
1 reference
Robert I Haddad
1 reference
Lisa J Weinstein
1 reference
Tad J Wieczorek
1 reference
Nandita Bhattacharya
1 reference
Harry Raftopoulos
1 reference
Martin W Oster
1 reference
Xinxin Zhang
1 reference
Vaughan M Latham
1 reference
Rosemary Costello
1 reference
Jarrod Faucher
1 reference
Carolyn DeRosa
1 reference
Murray Yule
1 reference
Linda P Miller
1 reference
Marshall R Posner
1 reference
Geoffrey I Shapiro
1 reference
1 July 2004
1 reference
1 reference
10
1 reference
14
1 reference
4680-4687
1 reference
Identifiers
1 reference
1 reference